Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive overview of the relationship between RET gene and tumor occurrence
Lu Zhao, Na Wang, Dou Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10

Showing 10 citing articles:

Advances in cancer genomics and precision oncology
Yong‐Seok Heo, Woo‐Jin Kim, Yong‐Joon Cho, et al.
Genes & Genomics (2025)
Closed Access
Molecular signatures of intrahepatic Cholangiocarcinoma: Role in targeted therapy selection
Tetiana Glushko, James Costello, Ranjit S. Chima, et al.
European Journal of Radiology (2025), pp. 112056-112056
Closed Access
A Clinical Viewpoint on the Use of Targeted Therapy in Advanced Gastric Cancer
Magdalena Skórzewska, Katarzyna Gęca, Wojciech Polkowski
Cancers (2023) Vol. 15, Iss. 22, pp. 5490-5490
Open Access | Times Cited: 5
Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma
R. Kothari, Sara Kreimer, Helen Nadel, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis
Jianhua Feng, Caixiu Wu, Fei Shen, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 1
First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors
W. Li, Yongsheng Wang, Anwen Xiong, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
REThinking the role of the RET oncogene in breast cancer
Giuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
RET Mutated Non-Small Cell Lung Cancer (NSCLC) in Association with Patients from Central America
Lily Z Chen, William J. Gibson, Brian C. Boulmay
Respiratory Medicine Case Reports (2024) Vol. 52, pp. 102118-102118
Open Access
Unlocking the Potential of Multigene Parallel Sequencing: A Concomitant Germline RET and BRCA1 Mutation in a Hereditary Medullary Thyroid Carcinoma
Amrit Kaur Kaler, Bora Nandini Shyamali, Upadhyay Shraddha Manoj, et al.
Archives of Case Reports (2024) Vol. 8, Iss. 3, pp. 126-130
Open Access
Genetic diversity and breed-informative SNPs identification in domestic pig populations using coding SNPs
Ichrak Hayah, Chouhra Talbi, Narjice Chafai, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
<i>RET</i> Alteration as a Predictive Biomarker in Cancer Immunotherapy
Yingying Li, Jinyuan Huang, Huimeng Yan, et al.
(2023)
Closed Access
Page 1

Scroll to top